EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differences in β-lactamase activity and carbapenem resistance among the Bacillus cereus group

Yuji Nishihara iD, Ryuichi Nakano iD, Akiyo Nakano iD, Yuki Suzuki iD, Miho Ogawa, Ryuji Sakata, Hisakazu Yano, Kei Kasahara

Antimicrobial Agents and Chemotherapy · 04.03.2026 · 70 (3)

DOI: 10.1128/aac.01302-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 04.03.2026. Verfasst von Yuji Nishihara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nara Medical University, Kashihara, Nara, Japan. Hauptthemen laut MEDLINE: beta-Lactamases, Bacillus cereus, Anti-Bacterial Agents, Carbapenems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Bacillus cereus group causes severe nosocomial infections. This group carries the chromosomal β-lactamases, including bla1 and BcII , which contribute to β-lactam resistance; however, the β-lactam resistance mechanisms are poorly understood. We performed genomic and phenotypic analyses of 48 clinical isolates from blood cultures and the reference strain ATCC14579 to clarify these mechanisms. Genomic analyses included species identification, multilocus sequence typing (MLST), and detection of β-lactamase genes using whole-genome sequencing. β-Lactam susceptibility testing, enzyme activity assays, and RT-qPCR of β-lactamases were performed. For this analysis, we developed a method to measure the enzyme activity of B. cereus group. The 48 isolates comprised three species (30 Bacillus mosaicus , 9 Bacillus cereus sensu stricto ( s.s .), and 9 Bacillus luti ) and 28 sequence types. Although all B. luti isolates lacked carbapenemase genes, they exhibited higher minimum inhibitory concentration (MIC) ranges for ampicillin and meropenem. The enzyme activity patterns were categorized as constitutive, inducible, or silent. All B. luti isolates and some B. mosaicus and B. cereus s.s . isolates displayed constitutive enzyme activity for penicillin G, whereas most B. mosaicus and B. cereus s.s . isolates displayed inducible activity, and five displayed silent activity. In the inducible group, the induced activity appeared to be accompanied by elevated penicillinase and carbapenemase expression. This is the first study to demonstrate interspecies variability within the B. cereus group regarding the presence of carbapenemase genes and β-lactam resistance profiles. These findings provide crucial insights into β-lactam resistance mechanisms in this bacterial group and provide a foundation for further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBacillus cereusAnti-Bacterial AgentsCarbapenemsbeta-Lactam ResistanceMicrobial Sensitivity TestsBacterial ProteinsMultilocus Sequence TypingHumansAmpicillinMeropenembeta Lactam Antibiotics

Stichwörter der Autor:innen

Bacillus cereus groupBacillus luticarbapenemaseenzyme activitymetallo-β-lactamase

Substanzen

beta-LactamasesAnti-Bacterial AgentsCarbapenemsBacterial ProteinsAmpicillinMeropenemcarbapenemasebeta Lactam Antibiotics

Autor:innen und Institutionen

  • Department of Infectious Diseases, Nara Medical University, Kashihara, Nara, Japan.
  • Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, Japan.
  • Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan.
  • Department of Bacteriology, BML Inc., Kawagoe, Saitama, Japan.

ORCID-Profile: Yuji Nishihara, Ryuichi Nakano, Akiyo Nakano, Yuki Suzuki

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Nishihara, Y., Nakano, R., Nakano, A., Suzuki, Y., Ogawa, M., Sakata, R., Yano, H., & Kasahara, K. (2026). Differences in β-lactamase activity and carbapenem resistance among the Bacillus cereus group. Antimicrobial Agents and Chemotherapy, 70(3). https://doi.org/10.1128/aac.01302-25

Vancouver

Nishihara Y, Nakano R, Nakano A, Suzuki Y, Ogawa M, Sakata R, et al. Differences in β-lactamase activity and carbapenem resistance among the Bacillus cereus group. Antimicrobial Agents and Chemotherapy. 2026;70(3). doi:10.1128/aac.01302-25

BibTeX
@article{Nishihara2026,
  author = {Nishihara, Yuji and Nakano, Ryuichi and Nakano, Akiyo and Suzuki, Yuki and Ogawa, Miho and Sakata, Ryuji and Yano, Hisakazu and Kasahara, Kei},
  title = {Differences in β-lactamase activity and carbapenem resistance among the Bacillus cereus group},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {3},
  doi = {10.1128/aac.01302-25}
}
Kostenlos starten →